510(k) K162219
K162219 is an FDA 510(k) premarket notification submitted by Smiths Medical Asd, Inc. for the device "CADD® Infusion Disposables Portfolio with NRFit connectors". The FDA issued a decision of Substantially Equivalent on July 20, 2017. The device falls under product code PWH (Administrations Sets With Neuraxial Connectors), a Class II device regulated under 21 CFR 880.5440. Smiths Medical Asd, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 20, 2017
- Date Received
- August 8, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Administrations Sets With Neuraxial Connectors
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type
The connector for neuraxial applications is intended to facilitate ANSI/AAMI/ISO 80369-6:2016 compliant neuraxial specific connections.